Keywords: pfizer, initiates, ph, trial, motilin, agonist, licensed

Pfizer initiates Ph I trial of motilin agonist licensed from Kosan Biosciences

Article | 13 August 2007

Print This

Pfizer has initiated a Phase I clinical trial of its selective and potent motilin receptor agonist PF-04548043. The drug, which ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in